New device seals Stroke-Causing heart pouch during bypass surgery

NCT ID NCT07360899

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a device called AtriLASH that closes a small heart pouch (the left atrial appendage) during planned heart surgery in 200 people with atrial fibrillation. The goal is to prevent blood clots that cause strokes, potentially reducing the need for blood-thinning medications. Researchers will check if the pouch stays closed after 3 months and track any strokes or bleeding events.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
AtriLASH device (suture-based closure device made of Seralene material)
What this could lead to
If successful, this could offer a safer way to reduce stroke risk in atrial fibrillation patients undergoing heart surgery, potentially allowing some to stop long-term blood thinners.
What could go wrong
This is a single-arm study with no comparison group, so benefits are uncertain. The device may not fully close the appendage, and risks like bleeding or embolism remain. Long-term stroke reduction is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTICOAGULANT THERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institute of cardiovascular diseases Vojvodina

    RECRUITING

    Kamenitz, Vojvodina, 21204, Serbia

More trials for these conditions

Other studies related to the condition(s) this trial covers.